Skip to content
10-Q

Quarterly Report

NEMAURA MEDICAL INC.

0001079973-24-000215

← back to feed
Filed
Feb 12, 2024 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2024 · Feb 12, 2024 28.9M sh
Shares Diluted Q3 2024 · Dec 31, 2023 28.9M sh
Shares Diluted Q3 2024 · Dec 31, 2023 28.9M sh
Shares Diluted Q3 2024 · Dec 31, 2022 24.1M sh
Shares Diluted Q3 2024 · Dec 31, 2022 24.1M sh
Capex Q3 2024 · Dec 31, 2023 $76.81K
Capex Q3 2024 · Dec 31, 2022 $275.76K
Operating Cash Flow Q3 2024 · Dec 31, 2023 −$7.2M
Operating Cash Flow Q3 2024 · Dec 31, 2022 −$6.09M
Long Term Debt Q3 2024 · Dec 31, 2023 $0
Long Term Debt Q3 2024 · Mar 31, 2023 $3.09M
Short Term Debt Q3 2024 · Dec 31, 2023 $19.64M
Short Term Debt Q3 2024 · Mar 31, 2023 $16.94M
Cash And Equivalents Q3 2024 · Dec 31, 2023 $137.42K
Cash And Equivalents Q3 2024 · Mar 31, 2023 $10.11M
Stockholders Equity Q3 2024 · Dec 31, 2023 −$17.83M
Stockholders Equity Q3 2024 · Sep 30, 2023 −$15.87M
Stockholders Equity Q3 2024 · Mar 31, 2023 −$11.81M
Stockholders Equity Q3 2024 · Dec 31, 2022 −$9.86M
Stockholders Equity Q3 2024 · Sep 30, 2022 −$8.7M
Stockholders Equity Q3 2024 · Mar 31, 2022 $466.08K
Current Liabilities Q3 2024 · Dec 31, 2023 $23M
Current Liabilities Q3 2024 · Mar 31, 2023 $22.27M
Total Liabilities Q3 2024 · Dec 31, 2023 $23M
Total Liabilities Q3 2024 · Mar 31, 2023 $26.38M
Current Assets Q3 2024 · Dec 31, 2023 $4.37M
Current Assets Q3 2024 · Mar 31, 2023 $13.54M
Total Assets Q3 2024 · Dec 31, 2023 $5.17M
Total Assets Q3 2024 · Mar 31, 2023 $14.56M
Eps Diluted Q3 2024 · Dec 31, 2023 −$0.07
Eps Diluted Q3 2024 · Dec 31, 2023 −$0.21
Eps Diluted Q3 2024 · Dec 31, 2022 −$0.07
Eps Diluted Q3 2024 · Dec 31, 2022 −$0.39
Eps Basic Q3 2024 · Dec 31, 2023 −$0.07
Eps Basic Q3 2024 · Dec 31, 2023 −$0.21
Eps Basic Q3 2024 · Dec 31, 2022 −$0.07
Eps Basic Q3 2024 · Dec 31, 2022 −$0.39
Sga Expense Q3 2024 · Dec 31, 2023 $1.25M
Sga Expense Q3 2024 · Dec 31, 2023 $4.32M
Sga Expense restated Q3 2024 · Dec 31, 2022 $1.23M
Sga Expense restated Q3 2024 · Dec 31, 2022 $1.51M
Rd Expense Q3 2024 · Dec 31, 2023 $291.1K
Rd Expense Q3 2024 · Dec 31, 2023 $1.33M
Rd Expense Q3 2024 · Dec 31, 2022 $393.75K
Rd Expense Q3 2024 · Dec 31, 2022 $980.86K
Net Income Q3 2024 · Dec 31, 2023 −$2.16M
Net Income Q3 2024 · Dec 31, 2023 −$5.97M
Net Income Q3 2024 · Dec 31, 2022 −$1.72M
Net Income Q3 2024 · Dec 31, 2022 −$9.46M
Operating Income Q3 2024 · Dec 31, 2023 −$1.54M
Operating Income Q3 2024 · Dec 31, 2023 −$5.65M
Operating Income restated Q3 2024 · Dec 31, 2022 −$1.62M
Operating Income restated Q3 2024 · Dec 31, 2022 −$2.49M
Gross Profit Q3 2024 · Dec 31, 2022 $46
Gross Profit Q3 2024 · Dec 31, 2022 $1.72K
Cost Of Revenue Q3 2024 · Dec 31, 2022 $2.97K
Cost Of Revenue Q3 2024 · Dec 31, 2022 $75.33K
Revenue Q3 2024 · Dec 31, 2022 $3.02K
Revenue Q3 2024 · Dec 31, 2022 $77.04K